Clinical experience with intravenous immunoglobulin and tnf-a inhibitor therapies for recurrent pregnancy loss.

Sills, Eric Scott; Walsh, David J; Shkrobot, Lyuda V; Palermo, Gianpiero D; Walsh, Anthony Ph

Sills, Eric Scott; Walsh, David J; Shkrobot, Lyuda V; Palermo, Gianpiero D; Walsh, Anthony Ph.

Ulster Med J ; 78(1): 57-8, 2009 Jan.

Article in En | MEDLINE | ID: mdl-19252735

Subject(s)

Immunoglobulin G/therapeutic use; Immunoglobulins, Intravenous/therapeutic use; Immunosuppressive Agents/therapeutic use; Receptors, Tumor Necrosis Factor/therapeutic use; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adult; Cesarean Section; Etanercept; Female; Humans; Infant, Newborn; Male; Pregnancy; Recurrence

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunoglobulin G / Tumor Necrosis Factor-alpha / Immunoglobulins, Intravenous / Receptors, Tumor Necrosis Factor / Immunosuppressive Agents Limits: Adult / Female / Humans / Male / Newborn / Pregnancy Language: En Journal: Ulster Med J Year: 2009 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google